Sign in to view content

Pradeepa Yoganathan Last Word

Pradeepa Yoganathan, MSc, MD, FRCS(C)

Video

Pradeepa Yoganathan Last Word

Related

Protocol U: Short-Term Evaluation of Combination Dexamethasone + Ranibizumab vs. Ranibizumab Alone for Persistent Central-Involv
Raj K. Maturi, MD
Updates from the Field
2017
Prophylactic Ranibizumab for Exudative AMD in Vulnerable Eyes With Nonexudative AMD Trial (PREVENT) A Prospective Controlled Clinical Trial
Maziar Lalezary, MD
Annual Meeting Talks
2018
ROP and Pediatric Vitreoretinopathies
Antonio Capone, MD
Webinars and Journal Clubs
2016

Category: The Last Word

See more